Intellia Therapeutics 주식 (NASDAQ: NTLA)

Intellia Therapeutics (NASDAQ:NTLA) 주식

Intellia Therapeutics

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock

Equities

News

Markets

ETFs

ARKF

ARKG

ARKK

ARKW

CDNA

GTLB

IBTA

NTLA

PATH

PRME

RBLX

RPTX

2025년 3월 14일 금요일, 캐시 우드가 이끄는 아크 인베스트가 깃랩(NASDAQ:GTLB), 인텔리아 테라퓨틱스(NGM:NTLA), 프라임 메디슨(NGM:PRME), 유아이패스(NYSE:PATH), 아이보타(NYSE:IBTA), 로블록스(NYSE:RBLX), 리페어 테라퓨틱스(NASDAQ:RPTX) 및 케어DX(NASDAQ:CDNA)에 대해 큰 매매를 했다.

아크 인베스트: 유아이패스와 로블록스 주식을 계속 처분, 깃랩과 아이보타를 매수

ABSI

ACCD

ARKQ

ARKX

ESLT

ILMN

OKLO

화요일(21일) 캐시 우드가 이끄는 아크 인베스트는 애콜레이드(NASDAQ:ACCD), 디어(NYSE:DE), 인텔리아 테라퓨틱스(NASDAQ:NTLA), 유아이패스(NYSE:PATH), 카메코(NYSE:CCJ), 오클로(NYSE:OKLO), 일루미나(NASDAQ:ILMN), 엘빗 시스템즈(NASDAQ:ESLT), 앱사이(NASDAQ:ABSI)와 관련된 상당한 거래를 진행했다. 

아크 인베스트, 트럼프의 정책에 따라 방산주·에너지주 투자

Biotech

Health Care

Tech

CRSP

GOOGL

ORCL

구글 모기업 알파벳의 자회사인 스타트업 아이소모픽 랩스(Isomorphic Labs)는 올해 연말까지 최초의 인공지능(AI) 설계 의약품의 임상시험을 시작할 예정이다. 주요 기술 기업들이 AI 기반 의료 솔루션에 대한 투자를 늘리면서 제약 개발의 중요한 이정표가 될 것으로 보인다.

알파벳 자회사 아이소모픽 랩스, 올해 말까지 AI가 설계한 신약 임상시험 예정

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

RBC Capital analyst Elvira Scotto maintains Genesis Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEL#NYSE">GEL</a>) with a Outperform and raises the price target from $14 to $15.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on Genesis Energy, Raises Price Target to $15

<a href="https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/8220799.pdf" title="https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/8220799.pdf">https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/8220799.pdf</a>

Politics

Trading Ideas

General

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MNST

MSFT

SCHW

TSCO

Wisconsin Congressman Tony Wied Purchased $15K-$50K And $100K-$250K Of Hims & Hers Health; Sold $50K-$100K Of Tractor Supply Co; Sold $100K-$250K Charles Schwab Corp; Purchased $100K-$250K Block, Inc.; Sold $100K-$250K Of Monster Beverage Corp; Purchased $100K-$250K Of Microsoft; All Transactions Notified On March 13, 2025

WIIM

MNDY

Monday.com shares are trading higher after DA Davidson upgraded its rating on the stock from Neutral to Buy.

Barclays analyst Alexia Dogani maintains ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) with a Underweight and lowers the price target from $16 to $13.5.

Barclays Maintains Underweight on ZIM Integrated Shipping, Lowers Price Target to $13.5

Li Auto shares are trading lower after Macquarie downgraded its rating on the stock from Outperform to Neutral.

RBC Capital analyst Nik Modi reiterates General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Sector Perform and maintains $70 price target.

Reiteration

RBC Capital Reiterates Sector Perform on General Mills, Maintains $70 Price Target

Chipotle Mexican Grill's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) short percent of float has fallen 23.39% since its last report. The company recently reported that it has 17.59 million shares sold short, which is 1.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.24 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Chipotle Mexican Grill Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742220928_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Chipotle Mexican Grill has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Chipotle Mexican Grill's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Chipotle Mexican Grill's peer group average for short interest as a percentage of float is 10.25%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Chipotle Mexican Grill?

Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) has outperformed the market over the past 20 years by 3.03% on an annualized basis producing an average annual return of 11.22%. Currently, Kroger has a market capitalization of $47.24 billion. 
Buying $100 In KR: If an investor had bought $100 of KR stock 20 years ago, it would be worth $843.28 today based on a price of $65.28 for KR at the time of writing.
<h3>Kroger's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742220924_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Kroger 20 Years Ago Would Be Worth Today

Entergy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) short percent of float has risen 37.3% since its last report. The company recently reported that it has 9.61 million shares sold short, which is 2.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.14 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Entergy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742220923_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Entergy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Entergy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Entergy's peer group average for short interest as a percentage of float is 2.23%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Entergy?

Beacon Roofing Supply's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NYSE">BECN</a>) short percent of float has fallen 26.82% since its last report. The company recently reported that it has 768 thousand shares sold short, which is 1.61% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Beacon Roofing Supply Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742220919_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Beacon Roofing Supply has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Beacon Roofing Supply's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Beacon Roofing Supply's peer group average for short interest as a percentage of float is 5.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BECN

How Do Investors Really Feel About Beacon Roofing Supply?

RBC Capital analyst Christopher Dendrinos initiates coverage on NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) with a Outperform rating and announces Price Target of $55.

Initiation

RBC Capital Initiates Coverage On NEXTracker with Outperform Rating, Announces Price Target of $55

Barclays analyst Mathieu Robilliard maintains TIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIMB#NYSE">TIMB</a>) with a Equal-Weight and raises the price target from $16 to $16.5.

TIMB

Barclays Maintains Equal-Weight on TIM, Raises Price Target to $16.5

Barclays analyst Brendan Lynch maintains Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) with a Overweight and raises the price target from $104 to $113.

Barclays Maintains Overweight on Crown Castle, Raises Price Target to $113

Quantum computing stocks are rising to start the week in potential anticipation of Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a href="https://www.benzinga.com/tech/25/03/44352209/gtc-2025-could-reignite-nvidias-stock-rally-but-only-if-b300-ai-server-roadmap-and-scaling-concerns-are-addressed-says-top-analyst">first ever Quantum Day</a>.
What To Know: Nvidia&#8217;s GTC 2025 event kicked off on Monday and runs through the end of the week. The AI conference will showcase breakthroughs happening in physical AI, agentic AI and scientific discovery. 
Nvidia will host its first Quantum Day at GTC 2025 on Thursday, bringing together key industry figures from the global quantum computing community. Nvidia CEO Jensen Huang will hold a two-hour panel Thursday morning, and he has a history of moving quantum names. 
Quantum stocks soared toward the end of 2024 on optimism surrounding technical advances, but the sector quickly sold off after Huang took the stage at CES 2025 and suggested that quantum computing could be two decades away from practical use.
&#8220;If you kind of said 15 years for very useful quantum computers, that would probably be on the early side. If you said 30, it&#8217;s probably on the late side. But if you picked 20, I think a whole bunch of us would believe it," Huang said at the consumer technology event.
Some of the biggest movers on Monday include D-Wave Quantum Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>), Quantum Computing Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>), Rigetti Computing Inc (NASDAQ;RGTI) and IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>). 
D-Wave Quantum boosted the sector last week after the company reported a more than 500% increase in fourth-quarter bookings. Several analysts lifted price targets on the stock following the print. 
Quantum Computing Inc is due to report its fourth-quarter financial results after the market close on Thursday. Analysts expect the company to report a loss of 5 cents per share, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
It&#8217;s worth noting that short seller Kerrisdale Capital <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44307671/is-high-flying-ionq-stock-a-disaster-in-the-making-shares-slide-as-short-seller-raises-red-flags">announced a short position</a> against IonQ last week, citing valuation concerns following the stock's recent surge.
"Despite retreating from all-time highs, shares still trade at a staggering 40x consensus 2026E revenue – a valuation that defies both logic and the warnings of former IonQ employees, who highlighted monumental scaling challenges that will derail the company&#8217;s ambitious plans," the short seller said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/top-stories/25/03/44313558/nvidia-stock-reached-all-time-highs-after-jensen-huangs-ces-keynote-will-next-weeks-gtc-spark-another-surge">Nvidia Stock Reached All-Time Highs After Jensen Huang&#8217;s CES Keynote — Will Next Week&#8217;s GTC Spark Another Surge?</a></li>
</ul>
Photo: courtesy of Nvidia.

Events

Movers

IONQ

NVDA

QBTS

QUBT

RGTI

Quantum Computing Stocks Are Rallying Monday: What's Going On?

Chardan Capital analyst Keay Nakae maintains Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) with a Buy and maintains $50 price target.

Chardan Capital Maintains Buy on Dyne Therapeutics, Maintains $50 Price Target

RBC Capital analyst Christopher Dendrinos initiates coverage on Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Sector Perform rating and announces Price Target of $7.

ARRY

RBC Capital Initiates Coverage On Array Technologies with Sector Perform Rating, Announces Price Target of $7

Shares of quantum stocks are trading higher in possible anticipation of Nvidia's Quantum Day.

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) with a Buy and maintains $65 price target.

Chardan Capital Maintains Buy on Avidity Biosciences, Maintains $65 Price Target

Despite the <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44275216/bitcoin-to-defy-trump-tariffs-recession-fears-will-hit-200000-by-end-of-2025-standard-chartered">current market uncertainty</a>, prominent crypto trader Michaël van de Poppe remains highly optimistic about Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and altcoins. 
What Happened: Van de Poppe argued on X on Monday that while sentiment feels low, market bottoms present the best buying opportunities, <a href="https://x.com/CryptoMichNL/status/1901319410280772010">adding</a> that this bull cycle is more complex than previous ones.
He pointed to several factors influencing subpar returns: 
<ul>
<li>The traditional 4-year Bitcoin cycle is no longer intact, largely due to Bitcoin ETF approvals, which accelerated new all-time highs.</li>
<li>Liquidity cycles remain critical markets are shifting from a tight financial environment to potential quantitative easing in the U.S. and China, which historically fuels bullish momentum.</li>
<li>Donald Trump's 2024 victory initially fueled expectations for a rapid crypto bull run, but his approach has been different from his first term, causing confusion. Despite this, the bull market is still likely—it's just playing out differently.</li>
</ul>
Rather than focusing on time-based cycles, Van de Poppe suggests traders watch price action and liquidity flows. 
He compares this phase to December 2020 before a major uptrend began.
Van de Poppe noted he is currently down ~45% on his altcoin holdings, but given historically low valuations, he sees this as reasonable and an opportunity to accumulate.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44339428/how-bitcoin-ethereum-have-outperformed-the-sp-500-since-2020-report">How Bitcoin, Ethereum Have Outperformed The S&amp;P 500 Since 2020: Report</a>
What's Next: Coinbureau co-founder Nick Puckrin noted that Bitcoin's correlation with altcoins is weakening. 
While some altcoins still move in sync with BTC, others are decoupling. 
Puckrin suggests focusing on altcoins with strong correlations to Bitcoin, as not all will follow BTC's uptrend.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The correlation between Bitcoin &amp; many altcoins is starting to break down. Some still remain positive but others are decoupling. Translation: If Bitcoin eventually continues its upward March, don&#39;t expect it to drag all alts with it. Focus on this with stronger correlation. <a href="https://t.co/Co0pcJuagv">pic.twitter.com/Co0pcJuagv</a>
&mdash; Nic (@nicrypto) <a href="https://twitter.com/nicrypto/status/1901506657051447456?ref_src=twsrc%5Etfw">March 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44354418/bitcoin-holds-steady-at-84000-as-wednesday-fomc-meeting-looms">Bitcoin Holds Steady At $84,000 As Wednesday FOMC Meeting Looms</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin, Altcoin Outlook Remains Positive, Says Defiant Trader Who's 45% Down On His Investments

BWS Financial analyst Hamed Khorsand maintains Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $172 price target.

IPAR

BWS Financial Maintains Buy on Interparfums, Maintains $172 Price Target

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NTLA

Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Lost Money on Intellia Therapeutics, Inc.(NTLA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Legal

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Intellia Therapeutics, Inc. (NTLA) Shareholders

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA

Small Cap

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA

Comments

Intellia Therapeutics

뉴스

파트너 / 기고자

벤징가 글로벌